IS PARKINSONS-DISEASE A MITOCHONDRIAL DISORDER

被引:55
|
作者
NAKAGAWAHATTORI, Y [1 ]
YOSHINO, H [1 ]
KONDO, T [1 ]
MIZUNO, Y [1 ]
HORAI, S [1 ]
机构
[1] NATL INST GENET,SHIZUOKA,JAPAN
关键词
PARKINSONS DISEASE; MITOCHONDRIAL MYOPATHY; LACTATE; PYRUVATE; COMPLEX-I; MITOCHONDRIAL DNA (MUSCLE);
D O I
10.1016/0022-510X(92)90205-Y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a common degenerative disease, but its etiology is still unknown. However, since the discovery of MPTP, many investigators have been interested in the mitochondrial function in PD. We investigated mitochondrial functions in PD patients using the methods which have successfully been applied to mitochondrial myopathies (MM), i.e. assay of lactate and pyruvate, measurement of muscle mitochondrial respiratory enzyme activities and Southern blot analysis of muscle mitochondrial DNA. Parkinson's disease patients did not differ from controls in the mean blood and CSF (cerebrospinal fluid) lactate and pyruvate levels at the basal resting state or during an aerobic exercise. But mitochondrial complex I activity of the skeletal muscle was significantly decreased in PD. In the Southern blot analysis, we could not find major deletions or insertions of mitochondrial DNA in PD. Our studies disclosed a differential mitochondrial impairment between PD and MM. We discuss the implication of our observation.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [21] MILACEMIDE THERAPY FOR PARKINSONS-DISEASE
    GIUFFRA, ME
    SETHY, VH
    DAVIS, TL
    MOURADIAN, MM
    CHASE, TN
    MOVEMENT DISORDERS, 1993, 8 (01) : 47 - 50
  • [22] POSTURAL INSTABILITY IN PARKINSONS-DISEASE
    BLOEM, BR
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1992, 94 : S41 - S45
  • [23] MORTALITY IN PATIENTS WITH PARKINSONS-DISEASE
    WERMUTH, L
    STENAGER, EN
    STENAGER, E
    BOLDSEN, J
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 92 (01): : 55 - 58
  • [24] PUPILLARY DYNAMICS IN PARKINSONS-DISEASE
    SUGIYAMA, T
    UTSUMI, T
    NEURO-OPHTHALMOLOGY, 1990, 10 (01) : 1 - 7
  • [25] PHARMACODYNAMICS OF LEVODOPA IN PARKINSONS-DISEASE
    NUTT, JG
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (11) : 837 - 840
  • [26] DEBRISOQUINE HYDROXYLATION IN PARKINSONS-DISEASE
    STEIGER, MJ
    LLEDO, P
    QUINN, NP
    MARSDEN, CD
    TURNER, P
    JENNER, PG
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (02): : 159 - 164
  • [27] VOIDING DYSFUNCTION IN PARKINSONS-DISEASE
    HATTORI, T
    YASUDA, K
    KITA, K
    HIRAYAMA, K
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1992, 46 (01): : 181 - 186
  • [28] TENDON JERKS IN PARKINSONS-DISEASE
    HAMMERSTAD, JP
    ELLIOTT, K
    MAK, E
    SCHULZER, M
    CALNE, S
    CALNE, DB
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 8 (1-2) : 123 - 130
  • [29] SELEGILINE IN THE TREATMENT OF PARKINSONS-DISEASE
    ROBIN, DW
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1991, 302 (06): : 392 - 395
  • [30] GLUTAMATERGIC DRUGS IN PARKINSONS-DISEASE
    LANGE, KW
    RIEDERER, P
    LIFE SCIENCES, 1994, 55 (25-26) : 2067 - 2075